Suchergebnisse - "Breccia, Massimo"

PubPharm (97)

1

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia : Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Oliva, E. | Riva, M. | Niscola, P. | +39

CommentIn: J Clin Oncol. 2023 Oct 1;41(28):4465-4468. - PMID 37428990

2

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts

enthalten in: American journal of hematology | 2023

von Lanino, L. | Restuccia, F. | Perego, A. | +63

3

Ruxolitinib in cytopenic myelofibrosis : Response, toxicity, drug discontinuation, and outcome

enthalten in: Cancer | 2023

von Palandri, F. | Breccia, M. | Mazzoni, C. | +37

4

Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs : 4-year phase 1 safety and efficacy results

enthalten in: Leukemia | 2023

von Mauro, M. | Hughes, T. | Kim, D. | +23

5

Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib

enthalten in: Blood cancer journal | 2023

von Palandri, F. | Elli, E. | Auteri, G. | +41

6

The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines : Findings from a Real-World Analysis in Italy

enthalten in: Advances in therapy | 2023

von Breccia, M. | Chiodi, F. | Nardozza, A. | +8

7

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib : 10-year followup of the GIMEMA CML 0307 study

enthalten in: Haematologica | 2022

von Gugliotta, G. | Castagnetti, F. | Breccia, M. | +23

8

Management of chronic myeloid leukaemia patients treated with ponatinib in a real-life setting : A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA)

enthalten in: British journal of haematology | 2022

von Breccia, M. | Olimpieri, P. | Celant, S. | +6

9

Myelodysplastic syndromes with del(5q) : A real-life study of determinants of long-term outcomes and response to lenalidomide

enthalten in: Blood cancer journal | 2022

von Gurnari, C. | Piciocchi, A. | Soddu, S. | +22

10

Management of Myelofibrosis during Treatment with Ruxolitinib : A Real-World Perspective in Case of Resistance and/or Intolerance

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Breccia, M. | Palandri, F. | Guglielmelli, P. | +7

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]